SCI期刊、EI期刊、北大 南大核心期刊发表

SCI期刊、EI期刊、北大 南大核心期刊发表

北大南大核心
您的位置:主页 > 北大南大核心 >

Circulation. Cardiovascular genetics期刊发表问题

手稿的编辑人员审查和专家评审的编辑指定的评估通常。临床和基础的文章也会受到统计审查,在适当的时候。临时或最终验收的基础上独创性,科
手稿的编辑人员审查和专家评审的编辑指定的评估通常。临床和基础的文章也会受到统计审查,在适当的时候。临时或最终验收的基础上独创性,科学的内容,该杂志的局部平衡。决策是通过电子邮件,一般六周内。编辑将不讨论一个电话手稿的决定。所有意见必须以书面形式向编辑部提交。
 
循环:心血管遗传学认为,所有类型的原始研究期刊,包括在人类受试者,进行了实验,实验动物,在体外和在硅片。文章包括调查:复杂的心血管疾病的分子遗传基础,包括全基因组关联,遗传连锁和候选基因;基因网络的功能,进化和结构的实验扰动研究;基因表达调控的表观遗传学,基因治疗,药物基因组学;谢组学;蛋白质组学;临床;诊断系统生物学的方法,与心血管疾病的管理。
 
请注意编辑邀请评期刊章。然而,不请自来的材料将被视为出版。
•Advances in Molecular Genetics, Genomics, Proteomics, Metabolomics and Systems Biology: Reviews will focus on topics of contemporary interest to the clinician, researchers, including young investigators. Overviews of experimental technologies, diagnostic strategies, and treatment approaches will be included in this series. In addition, the series will also include cutting edge reviews of the molecular basis of disease mechanisms and treatments, and will include molecular cardiology, genetic variation, genomics, transcriptomics, pharmacogenomics, and proteomics, metabolomics and systems biology.
•分子遗传学的进展,基因组学,蛋白质组学,谢组学和系统生物学:回顾将集中在当感兴趣的话题给临床医生,研究人员,包括年轻的研究人员。实验技术,诊断策略和治疗方法的概述,将包括在该系列。此外,该系列还包括减少疾病的机制和治疗的分子基础边缘的评论,并将包括分子心脏病学,遗传变异,基因组学,转录组学,基因组学和蛋白质组学,谢组学,系统生物学。
•Methods in Genetics and Clinical Interpretation: Reviews will bring insights from basic investigations into cardiovascular genetics and molecular biology into context for the clinician. This section would include discussion of genetics/genomics and other ‘omics’ tools; use of molecular biology tools such as genome browsers, bioinformatics, expression studies; design of pharmacogenetics studies; etc.
在遗传学和临床解释•方法:回顾将来自基本调查心血管遗传学和分子生物学的背景为临床医生。本节将包括遗传学/基因组学和其他“组学”工具的讨论;利用分子生物学的工具,如基因组浏览器,生物信息学,表达研究;药物遗传学研究设计等
•Controversies in Cardiovascular Genetics: Controversial topics in cardiovascular genetics will be presented in this series. Opposite viewpoints will be presented in tandem, with rebuttal responses by both authors included.
•争议在心血管遗传学:心血管遗传学有争议的议题将在本系列介绍。相反的观点将在串联反应,反驳的作者包括。
 
特殊路段
•Book Reviews: Reviews of selected books in cardiovascular genetics, including books that present innovative concepts, books that describe state-of-the-art diagnostic and therapeutic methods or important advances, and textbooks will be reviewed in this section. Unsolicited book reviews will be considered for publication online. In addition, authors or publishers may submit books, as well as a list of suggested reviewers, to the editorial office at the address noted above.
•书评:心血管遗传学的选书的评论,包括书籍,创新的概念,描述了最先进的诊断和治疗方法的重要进展,或书籍,教科书将在本节回顾。不请自来的书的评论将被视为出版在线。此外,出版商和作者可以提交的书,以及列出建议审稿者,给编辑部在上述地址。
•Cardiovascular Genetics: A News Round up: This section will have a synopsis of exciting developments in cardiovascular genetics based on publications in a panel of journals, with a focus on articles that will likely impact management of cardiovascular disorders.
•心血管遗传学:新闻综述:本节将有一个在心血管遗传学的基础上在一个面板的期刊出版物的令人兴奋的发展简介,文章将对心血管疾病可能影响管理的重点。
•Correspondence: Letters to the Editor, which pertain directly to an article published in the journal within the preceding 8 weeks, will be considered for publication online. A letter must not exceed 500 words in length and must be limited to three authors and five references. They should not have tables or figures. Authors of the original article cited in the letter will be invited to reply. Letters to the editor should be submitted via the online manuscript submission process as described below.
•对应:给编辑的信,它直接涉及到在杂志上发表的一篇文章的前8周内,将被视为出版在线。一封信必须不超过500字的长度必须限制在三位作者的五参考。他们不应该有表或数字。原文的信中引用的作者将被邀请的回复。给编辑的信应该通过在线投稿过程如下所述提交。

相关热词搜索: Circulation.,Cardiovascular,ge


上一篇:Cytometry A发表问题
下一篇:Pain期刊发表问题

联系方式

联系QQ:1299926851
免费咨询电话:1299926851

我们的优势

  • 规模优势

    30多人的研究及服务团队;国内设有3个办事处;研究院设有实验室。

  • 专业优势

    专注医学、生物学领域。

  • 诚信保证

    签订服务协议;可当面洽谈合作;业务经理可上门提供专业咨询

  • 标书、实验

    课题标书专业编辑;实验外包全面;科研成果期刊发表到位。

SCI发表常见问题

业务咨询